» Articles » PMID: 25819579

The Ability of Systemic Biochemical Markers to Reflect Presence, Incidence, and Progression of Early-stage Radiographic Knee and Hip Osteoarthritis: Data from CHECK

Overview
Date 2015 Mar 31
PMID 25819579
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To relate systemic biochemical markers of joint metabolism to presence, incidence, and progression of early-stage radiographic knee and/or hip osteoarthritis (OA).

Method: The cartilage markers uCTX-II, sCOMP, sPIIANP, and sCS846, bone markers uCTX-I, uNTX-I, sPINP, and sOC, and synovial markers sHA and sPIIINP were assessed by enzyme-linked immunosorbent assay or radioactive immunoassay in baseline samples of CHECK (Cohort Hip and Cohort Knee), a cohort study of early-stage symptomatic knee and/or hip OA. Knee and hip radiographs were obtained at baseline and 5-year follow-up. Presence of OA at baseline was defined as Kellgren and Lawrence (K&L) = 1 (maximum observed). Incidence of OA was defined as K&L = 0 at baseline and K&L ≥ 1 at 5-year follow-up. Progression of OA was defined as K&L = 1 at baseline and K&L ≥ 2 at 5-year follow-up.

Results: Data were available for 801 subjects at baseline and for 723 subjects at both baseline and 5-year follow-up. Multiple cartilage and synovial markers showed positive associations with presence and progression of knee and hip OA and with incidence of hip OA, except for negative associations of uCTX-II and sCOMP with incidence of knee OA. uCTX-II and sCOMP showed multiple interactions with other biomarkers in their associations with knee and hip OA. Bone markers were positively associated with presence of radiographic knee OA, but negatively associated with progression of radiographic hip OA.

Conclusion: Especially metabolism in cartilage and synovial matrix appear to be of relevance in knee and hip OA. The role of bone metabolism appears to differ between knee and hip OA.

Citing Articles

Longitudinal measurement of serum cartilage oligomeric matrix protein can detect the progression of cartilage degeneration in anterior cruciate ligament reconstruction patients.

Nishida Y, Hashimoto Y, Orita K, Nishino K, Kinoshita T, Iida K Asia Pac J Sports Med Arthrosc Rehabil Technol. 2024; 37:27-32.

PMID: 39091893 PMC: 11292425. DOI: 10.1016/j.asmart.2024.06.003.


An osteoarthritis pathophysiological continuum revealed by molecular biomarkers.

Kraus V, Sun S, Reed A, Soderblom E, Moseley M, Zhou K Sci Adv. 2024; 10(17):eadj6814.

PMID: 38669329 PMC: 11051665. DOI: 10.1126/sciadv.adj6814.


Dose-response relationship of in vivo ambulatory load and mechanosensitive cartilage biomarkers-The role of age, tissue health and inflammation: A study protocol.

Herger S, Vach W, Nuesch C, Liphardt A, Egloff C, Mundermann A PLoS One. 2022; 17(8):e0272694.

PMID: 35984848 PMC: 9390933. DOI: 10.1371/journal.pone.0272694.


The Concept of Early Osteoarthritis and Its Significance in Regenerative Medicine.

Im G Tissue Eng Regen Med. 2022; 19(3):431-436.

PMID: 35244885 PMC: 9130436. DOI: 10.1007/s13770-022-00436-6.


Can urinary CTX-II be a biomarker for knee osteoarthritis?.

Arunrukthavon P, Heebthamai D, Benchasiriluck P, Chaluay S, Chotanaphuti T, Khuangsirikul S Arthroplasty. 2022; 2(1):6.

PMID: 35236476 PMC: 8796402. DOI: 10.1186/s42836-020-0024-2.